Critical factors in the successful expansion of Pneumococcal Conjugate Vaccine in India during the COVID-19 pandemic

India had decided to roll out PCV in India in 2015, but successful implementation of any new vaccine introduction mandates an enormous effort. PCV was scaled up during the COVID-19 pandemic, which posed new, unprecedented challenges in the vaccine rollout. However, India successfully expanded PCV in...

Full description

Bibliographic Details
Main Authors: Seema Singh Koshal, Arindam Ray, Rhythm Hora, Amanjot Kaur, Syed F Quadri, Rashmi Mehra, Amrita Kumari, Pradeep Haldar, Arup Deb Roy
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Vaccine: X
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136223000694
Description
Summary:India had decided to roll out PCV in India in 2015, but successful implementation of any new vaccine introduction mandates an enormous effort. PCV was scaled up during the COVID-19 pandemic, which posed new, unprecedented challenges in the vaccine rollout. However, India successfully expanded PCV in the country in record time across all states and Union Territories.During the pandemic, supply-side restrictions, delayed vaccine shipments, staff shortages, and restrictions in conducting training negatively affected the roll-out of PCV across the country. However, despite the ongoing pandemic, India successfully rolled out PCV across the country in 7 months. In this review, the authors have conducted a narrative review to delineate the crucial factors that helped in the successful expansion of PCV.
ISSN:2590-1362